Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Kimura

Showing results (1-10 of 365) with videos related to

Pageof 37
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|December 15, 2010
AT-9283, a small-molecule multi-targeted kinase inhibitor for the potential treatment of cancerShinya Kimura
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Second generation Abl kinase inhibitors and novel compounds to eliminate the Bcr-Abl/T315I cloneShinya Kimura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 14, 2015
[State-of-the-art management of CML in 2015 and future prospects]Shinya Kimura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 4, 2026
[Key points in selecting first-line therapy for chronic myeloid leukemia]Shinya Kimura
Stem Cell Investigation|September 2, 2016
Current status of ABL tyrosine kinase inhibitors stop studies for chronic myeloid leukemiaShinya Kimura
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 29, 2014
[Possibility of the natural product extracted from Calophyllum Brasiliense]Shinya Kimura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 5, 2021
[Chronic myeloid leukemia: aiming for treatment free remission]Shinya Kimura
Clinical Calcium|April 2, 2008
[Cancer immunotherapy using gammadelta T cells ex vivo expanded by bisphosphonate]Shinya Kimura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2017
Molecular biology and treatment of CMLShinya Kimura
International Journal of Molecular Sciences|November 27, 2024
Current Understanding of the Role of Autophagy in the Treatment of Myeloid LeukemiaYasushi Kubota, Shinya Kimura
Pageof 37

Showing results (1-10 of 365) with videos related to

Sort By:
Pageof 37
Current Opinion in Investigational Drugs (London, England : 2000)|December 15, 2010
AT-9283, a small-molecule multi-targeted kinase inhibitor for the potential treatment of cancerShinya Kimura
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Second generation Abl kinase inhibitors and novel compounds to eliminate the Bcr-Abl/T315I cloneShinya Kimura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 14, 2015
[State-of-the-art management of CML in 2015 and future prospects]Shinya Kimura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 4, 2026
[Key points in selecting first-line therapy for chronic myeloid leukemia]Shinya Kimura
Stem Cell Investigation|September 2, 2016
Current status of ABL tyrosine kinase inhibitors stop studies for chronic myeloid leukemiaShinya Kimura
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 29, 2014
[Possibility of the natural product extracted from Calophyllum Brasiliense]Shinya Kimura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 5, 2021
[Chronic myeloid leukemia: aiming for treatment free remission]Shinya Kimura
Clinical Calcium|April 2, 2008
[Cancer immunotherapy using gammadelta T cells ex vivo expanded by bisphosphonate]Shinya Kimura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2017
Molecular biology and treatment of CMLShinya Kimura
International Journal of Molecular Sciences|November 27, 2024
Current Understanding of the Role of Autophagy in the Treatment of Myeloid LeukemiaYasushi Kubota, Shinya Kimura
Pageof 37